TRVI
Trevi Therapeutics, Inc. · Healthcare
President and CEO Jennifer L Good sold $170K of Trevi Therapeutics, Inc.
Sold$170,193
$3.09Price
55,121Shares
−21%Stake
What TRVI did after the filing
- The stock from Thu, Sep 5 close, $3.10
- +0.6%
- S&P 500, same days
- +6.3%
Measured over 30 trading days, to the Oct 17 close.
Traded Tue, Sep 3. Filed Thu, Sep 5, 12:54 PM ET, during the session. Returns use the Sep 5 close and the Oct 17 close. Not investment advice.